Moderna (MRNA) shares fell 7% to $135.22 in early trading Monday, after rising 392% year-to-date, as traders opted for profit-taking in the absence of new negative catalysts. Over the same period, BioNTech (BNTX) shares fell 4% to $111.47, and Merck (MRK) shares fell 1% to $150.61.